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ABSTRACT
Objectives: Although well established, the association
between socioeconomic position and health and health
behaviour is not clearly understood, and it has been
speculated that familial factors, for example,
dispositional factors or exposures in the rearing
environment, may be underlying the association. The
objective was to compare prescription fillings within
twin pairs who are partly or fully genetically identical
and share childhood exposures.
Design: Twin cohort study.
Setting: Denmark.
Participants: Data from the Danish Twin Registry
were linked to registers in Statistics Denmark and the
Danish Registry of Medicinal Product statistics. A total
of 8582 monozygotic (MZ) and 15 788 dizygotic same
sex (DZSS) twins were included.
Outcome measures: Number of prescription fillings
during follow-up (1995–2005) was analysed according
to education and income. Results of unpaired and
intrapair analyses were compared.
Results: An inverse social gradient in filling of
prescriptions for all-purpose and system-specific drugs
was observed in the unpaired analyses. In the intrapair
analyses, associations were attenuated some in DZSS
and more in MZ twins. Filling of drugs targeting the
nervous system was still strongly associated with
income in the intrapair analyses.
Conclusions: Familial factors seem to account for
part of the observed social inequality in filling of
prescription medicine.
INTRODUCTION
Social inequalities in health and health behav-
iour have been widely demonstrated in many
societies, including the Scandinavian coun-
tries.1 Often social disparities in health are not
conﬁned to the most marginalised groups of
society but are expressed as a gradient over the
entire spectrum of social stratiﬁcation.2 The
inverse relationship between socioeconomic
position (SEP) and health has consistently
been observed across different social
indicators and for numerous types of health
outcomes.3 4 Use of prescription medicine is
one health-related outcome that has been
found to be socially patterned, where Danish
data have shown a greater use among people
with low SEP compared with people with high
SEP.5 6 Denmark has a tax-ﬁnanced decentra-
lised healthcare system with a partly need-
dependent reimbursement system for out-
patient prescription drugs. All prescription
drugs have to be prescribed by a medical
doctor and, compared with a number of other
countries, prescription medicine constitute
the majority of the total drug sales in
Denmark (approximately 90%).7 Many studies
have shown substantially reduced social differ-
ences in drug use when health status have
Strengths and limitations of this study
▪ This study is based on nation-wide register data
covering more than a decade, and we present
results from a largely unselected population of
more than 8000 monozygotic and 15 000 dizyg-
otic same sex twins.
▪ This is the first twin study on health inequalities
to report such clear-cut findings with sufficient
power for meaningful interpretation of intrapair
analyses and for comparison of zygosity-specific
results.
▪ Prescription fillings are not a perfect measure of
health status, but we still argue that it is an
inventive and fairly valid indicator in a Danish
setting where prescription medicine has to be
prescribed by a medical doctor and accounts for
90% of the total drug sale.
▪ The twin study is clearly a powerful approach,
but when interpreting findings, alternative expla-
nations for the pattern of attenuation should be
considered, including measurement error and
unshared confounding. However, in this case we
find it unlikely that these potential sources of
bias could fully explain our findings.
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been taken into account,6 8 9 which may indicate that
ﬁlling of prescription medicine to a large extent reﬂects
health status. This is supported by the fact that comorbid-
ity indices, based on prescription drug dispensings, have
been established as strong predictors of mortality,10 and
that drug use has proven to be a valid indicator of self-
rated health.11 12 However, other factors such as health-
care seeking behaviour and access to healthcare13 14 may
also inﬂuence drug use, but the social gradient in these
factors would, theoretically, be expected to be opposite
that of health status, that is, greater drug use among
people with high SEP compared with low SEP. Such a posi-
tive association is generally not supported by the existing
Danish literature.5 6 15
Although well established, the inverse association
between SEP and health and health behaviour is not
clearly understood, but many factors during the life
course may play a role in the production of these social
health differences. Suggested pathways include: material
deprivation, behavioural factors and psychological
factors.16 It has also been suggested that it is not SEP in
adulthood per se that inﬂuences health, but underlying
familial factors already at play in early life,17 18 for
example, rearing environment or genetic make-up are
associated both with the obtainment of adult SEP and
health status later in life.
In a recent commentary, Gilman and Loucks19 discuss
why childhood environment may be such an important
underlying factor in the production of social health dif-
ferences. They argue that because childhood encom-
passes developmentally sensitive periods for the
acquisition of cognitive, psychological and social skills
that have a profound impact on an individual’s capacity
for long-term health and provide opportunities (and
constraints) for adult socioeconomic conditions, it can
potentially inﬂuence the association between any adult
risk factor and later life health.19 The potential role of
genetic setup in explaining health inequalities is
reviewed by Mackenbach,20 who suggests that the most
plausible set of hypotheses relates to genetic inﬂuences
of personal attributes such as cognitive ability, personal-
ity and bodily and mental ﬁtness that may inﬂuence
both SEP and adult health status.
With the discordant twin pair design, it is possible to
investigate the effect of adult SEP on prescription ﬁllings
eliminating confounding from factors shared by a pair of
twins, exploiting that twins are partly or fully genetically
identical and have experienced a similar childhood envir-
onment due to their common upbringing. This approach
has been applied in a number of previous twin studies
investigating different health outcomes, including mor-
tality,21 hospitalisations,22 breast cancer23 and also softer
endpoints such as depression scores and self-rated
health.24 25 However, the majority of these studies suffer
from power limitations either due to small sample sizes
and/or rare outcomes, making interpretations difﬁcult.
In this study we aimed to investigate if there was an
effect of SEP in adulthood on the number of
prescription ﬁllings above and beyond the effect of
shared familial factors. Filling of prescription medicine
is a quantitative health measure rendering sufﬁcient
power for the intrapair comparisons. Differences in
genetic relatedness between monozygotic (MZ; genetic-
ally identical) and dizygotic (DZ) twins (share on
average 50% of segregating genes) may further give an
indication of the possible types of confounding (ie,
genetic or environmental factors). In the theoretical
situation of no measurement error and no confounding
from unshared factors, genetic confounding would be
indicated if an observed social gradient in prescription
medicine was partly attenuated in DZ twins and fully
attenuated in MZ twins, when shared familial factors had
been taken into account. Likewise, an attenuation of
similar size in DZ and MZ twins would be compatible
with shared environmental confounding. Finally, to
support a SEP effect on prescription ﬁllings not due to
confounding from shared familial factors, the associ-
ation would have to persist in both DZ and MZ twins.
To support the utility of prescription medicine as a
health indicator we also analysed its association with
mortality.
METHODS
Study population
Data from the Danish Twin Registry were linked with
information in the Danish Registry of Medicinal
Products and administrative registers in Statistics
Denmark. The study population consisted of 24 370
twins, including 8582 MZ and 15 788 dizygotic same sex
(DZSS) twins, who were born during 1921–1965 and
alive and resident in Denmark at the beginning of
follow-up (1 January 1995), after exclusions due to tri-
plets (n=384) unknown zygosity (UZ; n=3731), and
dizygotic opposite sex pairs (n=16 710), missing data on
education or income (n=845) and non-intact twin pairs
in which one twin was dead, emigrated or had missing
information (n=2847). To evaluate the representative-
ness of the results from the unpaired twin analyses, we
also analysed a 5% population-based sample of the
Danish population (n=137 300).
Social indicators
We used information on the highest attained education
in 1995 at age of 30+ of the study population, cate-
gorised according to the International Standard
Classiﬁcation of Education of 199726 into: primary/
lower secondary education (basic compulsory educa-
tion), upper secondary education (secondary) and ter-
tiary education (Bachelor’s degree and above). Income
was measured as an average of the equivalised gross
household income (Danish currency) in 1994–1995,
grouped into quartiles within each birth cohort.
‘Equivalised’ income is adjusted to take into account
that households can share resources. Inspired by the
standard Organisation for Economic Co-operation and
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Development equivalence scale,27 the household-
denominator was constructed according to an equiva-
lence scale that assigned a value of 1 to the ﬁrst house-
hold member, of 0.7 to the second household member
and of 0.5 to each additional household member.
Calculating quartiles by birth cohort is aiming at taking
into account that income is not fully comparable at dif-
ferent ages during the life course. An implication of this
is that the income measure reﬂects a relative rather than
absolute income level.
Prescription medicine
The Danish Registry of Medicinal Products was estab-
lished in 1995 and contains information on the total
sale of prescription medicine in Denmark registered by
the pharmacies via a computerised accounting system.
The drug information is recorded according to the
Anatomical Therapeutic Chemical classiﬁcation system
(ATC)28 where the active substances in drugs are divided
into different groups, primarily according to the organ
system on which they act. Other information includes
date of dispensing and daily deﬁned doses (DDD), deﬁned
as the assumed average maintenance dose per day for a
drug used for its main indication in adults.28 Outcomes
of interest were deﬁned as the number of prescription
ﬁllings during follow-up for all-purpose medication
(ACT-groups: A, B, C, D, G, H, J, L, M, N, P, Q, R, S, V,
excluding Q which is for veterinary use, and G02B and
G03A, which are for contraceptive use) and four groups
of system-speciﬁc medication: ATC-C (heart/circulatory
system), ATC-N (nervous system), ATC-R (respiratory
system) and ATC-A (alimentary tract/metabolism). If no
ATC code was assigned a prescription, it was excluded
(1%). DDD was used as a supplementary outcome
measure.
Other covariates
Sex and age were included in the analyses. Analyses
were performed separately for MZ and DZSS twins.
Zygosity had previously been determined by question-
naire,29 a method that has proven valid with an overall
misclassiﬁcation frequency of less than 5% validated
against a classiﬁcation based on genetic markers.30
Data analysis
Analyses were carried out using Cox regression for recur-
rent events (proportional means regression), thereby
accommodating multiple events (prescription ﬁllings)
per individual.31 Age was used as underlying time-
variable and participants were followed from age at base-
line to the age at the end of follow-up (31 December
2005) or death or emigration, and the timing of each
prescription ﬁlling during this period was recorded.
Both unpaired and intrapair analyses were performed.
In the unpaired analyses robust SEs were used to
account for the interdependence of observations within
pairs and within each individual. Results of the unpaired
analyses were compared with the intrapair analyses,
which were performed using a stratiﬁed Cox model:
ENij(t)=μ0j(t)e
β’z_ij. Here ENij(t) denotes the mean
number of prescription ﬁllings at time t for an individ-
ual i belonging to twin pair j, μ0j(t) the pair-speciﬁc
baseline mean, and eβ the effect of the covariates
adjusted for shared familial factors. Thus, in this analysis
the mean number of prescription ﬁllings was compared
within twin pairs, thereby controlling for familial factors
shared by a pair of twins. In the stratiﬁed model only
SEP-discordant twin pairs contribute information to the
β-parameter for SEP, although concordant pairs may
contribute information to other β-parameters.
As counting process models do not allow simultaneous
events, only one prescription of interest per day was
included in the analysis.
Analyses were performed separately for zygosity and
sex, and potential interactions between the social indica-
tors and zygosity, sex and age, respectively, were evalu-
ated by including interaction terms in the models and
using Wald test statistics. To analyse the association
between prescriptions and mortality, we used a Cox
regression model, continuously updating the number of
prescription ﬁllings over time. Descriptive intrapair cor-
relations were calculated as polychoric correlation
coefﬁcients.
Subanalyses
Since DDD may reﬂect the actual drug use more pre-
cisely than the number of prescription ﬁllings, mean
DDD were also analysed by means of a ﬁxed-effects
linear regression model taking censoring into account.32
This was treated as a subanalysis due to the highly right-
skewed distribution of DDD, making linear regression a
less optimal choice of model.
Permission for linkage and use of data for this study
was obtained from the Danish Data Protection Board
(2000-54-0047).
RESULTS
According to table 1, showing the distribution of educa-
tion and income in the population, men were better
educated than women. Generally, the education of the
twin population was comparable to that of the
population-based sample. Only UZ twins had a markedly
lower educational status and a higher proportion of
missing information. The table also shows the mean
income within each quartile. Twins have a somewhat
higher mean income as compared to the population-
based sample.
The proportion of education-discordant twin pairs was
30% for MZ twins and 42% for DZSS twins, while 61%
MZ twins and 68% DZSS twins were discordant on
income (table 2).
In the twin population, 1.9% did not redeem any drug
prescriptions during the total follow-up period and 25%
redeemed less than one prescription/year, on average
(results not shown). Overall, women ﬁlled more
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Table 1 Descriptives on educational status and income in a 5% population-based sample (n=144 749) and a population of Danish twins (n=48 887), including intact and
non-intact twin pairs, stratified on sex and zygosity
5% Population sample All twins DZSS MZ DZOS UZ
N Per cent* Mean SD (n=48 887) Mean SD (n=18 426) (n=9636) (n=16 710) (n=3731)
Sex N Per cent * N Per cent * N Per cent * N Per cent * N Per cent *
Educational status†
Men
Primary 23 550 32 8909 35 3553 36 1517 31 2882 34 957 43
Secondary 31 336 43 11 237 44 4309 44 2292 47 3834 45 802 36
Tertiary 13 722 19 4515 18 1685 17 963 20 1530 18 337 15
Missing 4072 6 800 3 310 3 128 3 208 2 154 7
Total 72 680 100 25 461 100 9857 100 4900 101 8454 99 2250 101
Women
Primary 31 215 43 10 182 44 3857 45 1903 40 3633 44 789 53
Secondary 23 809 33 7805 34 2868 34 1730 37 2807 34 400 27
Tertiary 14 229 20 4613 20 1696 20 1004 21 1705 21 208 14
Missing 2816 4 442 2 148 2 99 2 111 1 84 6
Total 72 069 100 23 042 100 8569 101 4736 100 8256 100 1481 100
Income‡ (DKK)
Men
1st quartile 17 348 24 88 537 28 373 5931 24 92 330 27 563 2251 23 1061 22 1929 23 690 31
2nd quartile 17 510 24 145 676 25 887 6523 24 149 367 24 179 2563 26 1208 25 2201 26 551 24
3rd quartile 17 976 25 191 360 34 863 6769 25 196 738 31 365 2612 27 1375 28 2246 27 536 24
4th quartile 18 228 25 311 232 141 784 5960 25 314 180 225 459 2340 24 1218 25 2006 24 396 18
Missing 1618 2 278 2 91 1 38 1 72 1 77 3
Total 72 680 100 25 461 100 9875 101 4900 101 8454 101 2250 100
Women 2174 25 1158 24 2200 27 538 36
1st quartile 18 958 26 88 201 26 316 6070 26 91 205 25 698 2316 27 1222 26 2186 27 353 24
2nd quartile 18 219 25 142 746 27 689 6077 25 146 427 25 562 2152 25 1224 26 2106 26 313 21
3rd quartile 17 753 25 18 942 36 067 5795 25 194 968 33 291 1882 22 1097 23 1730 21 232 16
4th quartile 16 126 22 308 876 225 888 4941 22 312 063 173 113 45 1 35 1 34 0 45 3
Missing 1013 1 159 1 8569 100 4736 100 8256 101 1481 100
Total 72 069 99 23 042 99 2251 23 1061 22 1929 23 690 31
*May not sum to 100 because of rounding.
†International Standard Classification of Education.
‡Average of equivalised gross household income in 1994–1995 in quartiles.
DKK, Danish crowns; DZOS, dizygotic opposite sex twins; DZSS, dizygotic same sex twins; MZ, monozygotic twins; UZ, unknown zygosity.
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prescriptions than men for all age groups and the
number of prescription ﬁllings increased with age in
both sexes (table 3).
ATC-N drug prescriptions were the most frequently
redeemed in the youngest age group. The mean
number of prescription ﬁllings in the twin population
was similar to that in the population-based sample,
although slightly higher in the population-based sample.
In order to get a better idea of the clinical outcomes
underlying the observed prescription patterns, we have
included a more detailed description of the most inci-
dent types of drugs at the 3-digit and 4-digit ATC level
(see online supplementary table S1). From the table it
appears that the ATC-C category primarily comprises
drugs indicated for hypertension and ischaemic heart
disease, while the ATC-N category includes drugs indi-
cated for a wide range of different diagnoses, including
chronic pain disorders, insomnia, anxiety, psychoses,
depression, etc.28 In the ATC-R category the main types
of drugs are drugs for obstructive airway disease such as
asthma and chronic obstructive lung disorder
(COPD).28 Finally, drugs for acid-related disorders and
diabetes are the main constituents of the ATC-A cat-
egory. The results of an analysis of the association
between SEP and prescription ﬁllings for all-purpose
and system-speciﬁc drugs are presented in table 4.
For all-purpose drugs, MZ twins in the highest income
quartile had a 30% lower mean number of prescription
ﬁllings than MZ twins in the lowest income quartile
(MR=0.70 (95% CI 0.65 to 0.77)). Similarly, MZ twins
with a tertiary education had 17% lower mean number
of prescription ﬁllings than twins with a primary educa-
tion (MR=0.82 (95% CI 0.75 to 0.89)). The association
was slightly less strong for ATC-C drugs while stronger
associations could be observed for the other system-
speciﬁc drugs, particularly for ATC-N. In the unpaired
analyses, no large differences could be observed
between MZ and DZSS twins and there was no strong
evidence for an interaction between SEP and zygosity in
the unpaired analysis (education p=0.81, income
p=0.95). In contrast, the effect of SEP was moderated by
zygosity in the intrapair analyses (education p=0.02,
income p=0.05), suggesting a more attenuated effect of
SEP in MZ twins than in DZSS twins. In MZ twins, gener-
ally no statistically signiﬁcant effect of education could
be observed, while income was still somewhat associated
with all-purpose medication and quite strongly with
ACT-N drugs. In DZSS twins, a minor or moderate
attenuation could be observed, and all effect parameters
were statistically signiﬁcant, except for ATC-C drugs. In
the population-based sample, the associations were
similar to that in the overall twin population.
When using DDD (for all-purpose drugs) as outcome
measure (table 5), results similar to the results based on
the number of prescription ﬁllings were obtained,
although the attenuation patterns in MZ twins were
somewhat more clear in this analysis, showing no statis-
tically signiﬁcant associations with DDD of neither edu-
cation nor income. In the analysis of number of
prescriptions as a predictor of mortality, we found a 60%
increase in mortality rate during follow-up for a person
who, on average, ﬁlled one prescription per month
during the follow-up period compared with a person
without any prescription ﬁllings (HR=1.60 (95% CI 1.25
to 2.05)).
DISCUSSION
Summary of findings
In this large Danish twin population we demonstrated
an inverse social gradient in ﬁllings of prescription
medicine for all-purpose and system-speciﬁc drugs. That
Table 2 Descriptives on intrapair discordances on educational status and income, stratified on zygosity in a population of
Danish twins (n=24 370)
DZSS MZ
(n=15 788) (n=8582)
N Per cent* N Per cent*
Educational status
Primary vs secondary 3590 23 1460 17
Primary vs tertiary 900 6 316 4
Secondary vs tertiary 2194 14 820 10
Any discordance 6684 42 2596 30
Income
1st quartile vs 2nd quartile 2048 13 1072 12
1st quartile vs 3rd quartile 1706 11 754 9
1st quartile vs 4th quartile 1158 7 490 6
2nd quartile vs 3rd quartile 2266 14 1194 14
2nd quartile vs 4th quartile 1574 10 682 8
3rd quartile vs 4th quartile 2000 13 1080 13
Any discordance 10 752 68 5272 61
*May not sum to 100 because of rounding.
DZSS, dizygotic same sex twins; MZ, monozygotic twins.
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is, a greater use of prescription medicine among those
with a low SEP thus suggesting a worse health status of
this group. Furthermore, the number of prescription ﬁll-
ings was shown to be associated with a greater risk of
mortality. In the intrapair analyses, where shared familial
factors were controlled per design, the association
between SEP and prescription ﬁllings attenuated to a
wide extent within MZ twins and statistically signiﬁcantly
less in DZSS twins. For education, there was generally no
association with prescription ﬁllings in the intrapair ana-
lyses of MZ twins, except for drugs targeting the nervous
system, while there was still some association of income
with all-purpose medication and most system-speciﬁc
drugs. However, no effect of income was seen in the
intrapair analyses when DDD were used as outcome
measure. In spite of some variations between system-
speciﬁc drugs, the overall pattern was the same as for all-
purpose drugs, except for ATC-N drugs and to a lesser
degree ATC-A drugs, which still showed some effect of
SEP in the intrapair analyses.
Interpretation
The fact that the association was attenuated in the intra-
pair analyses suggests that underlying factors shared by a
pair of twins account for some of the observed associ-
ation between SEP and prescription ﬁllings. However,
there may be a number of alternative or complementary
explanations for this ﬁnding: ﬁrst, part of it is likely
caused by measurement error. Measurement error is
random and therefore not shared by twins. In the intra-
pair analysis, variance due to shared factors is removed,
and a relatively larger proportion of exposure variance is
thus due to measurement error. This will result in
increasing attenuation of parameter estimates in the
intrapair analyses.33 However, since data come from ofﬁ-
cial registers it can be expected that education and
income have limited measurement error. Second, the
behaviour of one twin could be affected by the behav-
iour of the other twin, that is, ‘social interaction’ either
by ‘imitation’ or ‘differentiation’. The implications of a
potential imitation could be smaller within-pair differ-
ences, which could be misinterpreted as confounding
from underlying familial factors. This may be of some
concern in this study since ﬁllings of prescription medi-
cine is likely to have a behavioural component. Another
implication of the discordant twin pair approach is that
only twin pairs who are discordant on exposure contrib-
ute with statistical information to the estimation of SEP
effects in the intrapair analysis. This could potentially
induce bias in the comparison of the unpaired and
intrapair analysis, since the two analyses are based on
only partly overlapping populations. Since MZ twins are
less likely to be discordant, the selection bias may be
most severe in MZ twins.34 We examined this concern by
restricting the unpaired analysis only to include groups
with exposure-discordant twins. Results were similar to
Table 3 Mean number of prescription fillings after 1 and
10 years of follow-up in a 5% population-based sample
and a population of Danish twins, stratified on age and sex
Type of drugs Nelson-Aalen cumulative hazard
Age
5% Population
(n=137 300) Twins (n=24 370)
Sex 1 year 10 years 1 year 10 years
All purpose
30–44 years
Men 2.5 28.7 2.2 25.9
Women 4.1 44.5 3.8 41.1
45–59 years
Men 3.6 47.4 3.3 43.1
Women 6.0 71.9 5.7 68.4
60+ years
Men 6.4 87.5 5.8 82.2
Women 8.3 105.4 7.2 95.7
Circulatory system (ATC-C)
30–44 years
Men 0.1 3.3 0.1 2.9
Women 0.2 4.2 0.2 3.6
45–59 years
Men 0.7 12.6 0.6 10.6
Women 0.8 13.8 0.7 13.0
60+ years
Men 1.9 29.6 1.7 27.4
Women 1.9 30.0 1.6 26.7
Nervous system (ATC-N)
30–44 years
Men 0.8 9.8 0.7 8.6
Women 1.1 14.5 1.0 13.3
45–59 years
Men 1.2 14.6 1.2 13.9
Women 2.1 25.0 2.0 24.1
60+ years
Men 1.8 24.4 1.6 22.2
Women 3.1 39.2 2.7 35.8
Respiratory system (ATC-R)
30–44 years
Men 0.3 3.9 0.3 3.6
Women 0.6 6.5 0.5 5.7
45–59 years
Men 0.5 5.8 0.4 5.0
Women 0.8 9.8 0.7 9.1
60+ years
Men 1.1 14.4 0.9 12.5
Women 1.2 14.8 1.0 12.8
Alimentary tract and metabolism (ATC-A)
30–44 years
Men 0.3 3.5 0.2 3.1
Women 0.4 5.0 0.4 4.1
45–59 years
Men 0.5 7.6 0.5 6.6
Women 0.7 9.6 0.7 8.6
60+ years
Men 1.1 15.4 1.1 15.0
Women 1.3 18.3 1.0 16.4
ATC, Anatomical Therapeutic Chemical classification system.
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those of the main analysis in both MZ and DZ twins.
A further issue relates to the fact that twins who are dis-
cordant on exposure are special in the sense that they,
in spite of overlapping genes and rearing environment,
differ in their SEP. Thus, unshared factors may explain
these differences. This implies that the intrapair analysis
may still be confounded by unshared confounding
factors, and that this confounding may be enforced in
Table 4 Ratio (MR) of the mean number of prescription fillings (1995–2005) for all-purpose and system-specific drugs
according to educational status and income in a 5% population-based sample (137 300) and a population of Danish twins
(n=24 370), showing results from unpaired and intrapair analyses stratified on zygosity
Unpaired analysis* Intrapair analysis†
5% Population
n=137 300
Twins
DZSS n=15 788 MZ n=8582 DZSS MZ
Type of drug MR 95% CI MR 95% CI MR 95% CI MR 95% CI MR 95% CI
All purpose
Education
Secondary 0.90 0.90 to 0.90 0.90 0.86 to 0.95 0.87 0.81 to 0.93 0.88 0.84 to 0.93 0.97 0.91 to 1.03
Tertiary 0.82 0.82 to 0.83 0.85 0.80 to 0.91 0.83 0.76 to 0.90 0.86 0.80 to 0.92 0.95 0.86 to 1.05
Income
2nd quartile 0.78 0.78 to 0.78 0.81 0.76 to 0.85 0.81 0.75 to 0.88 0.86 0.82 to 0.91 0.91 0.85 to 0.97
3rd quartile 0.72 0.72 to 0.73 0.72 0.69 to 0.77 0.74 0.69 to 0.80 0.79 0.75 to 0.83 0.87 0.81 to 0.94
4th quartile 0.70 0.70 to 0.70 0.71 0.67 to 0.75 0.70 0.65 to 0.77 0.76 0.72 to 0.81 0.87 0.81 to 0.94
Circulatory system (ATC-C)
Education
Secondary 0.95 0.95 to 0.96 0.92 0.85 to 0.99 0.87 0.78 to 0.96 0.85 0.79 to 0.92 0.89 0.81 to 0.97
Tertiary 0.79 0.79 to 0.80 0.78 0.71 to 0.87 0.70 0.60 to 0.82 0.80 0.71 to 0.90 0.93 0.79 to 1.08
Income
2nd quartile 0.91 0.90 to 0.91 0.94 0.87 to 1.03 0.94 0.84 to 1.06 1.08 0.99 to 1.17 0.95 0.87 to 1.05
3rd quartile 0.83 0.83 to 0.84 0.86 0.78 to 0.94 0.86 0.76 to 0.97 0.97 0.89 to 1.06 0.98 0.89 to 1.08
4th quartile 0.79 0.79 to 0.79 0.82 0.74 to 0.90 0.85 0.74 to 0.97 0.97 0.88 to 1.08 0.94 0.84 to 1.05
Nervous system (ATC-N)
Education
Secondary 0.80 0.80 to 0.80 0.87 0.79 to 0.96 0.77 0.67 to 0.88 0.85 0.77 to 0.94 1.00 0.86 to 1.17
Tertiary 0.71 0.71 to 0.71 0.77 0.67 to 0.88 0.75 0.61.0.92 0.78 0.67 to 0.90 0.91 0.73 to 1.16
Income
2nd quartile 0.61 0.60 to 0.61 0.61 0.55 to 0.68 0.60 0.52 to 0.70 0.68 0.61 to 0.75 0.75 0.67 to 0.87
3rd quartile 0.49 0.49 to 0.50 0.47 0.43 to 0.53 0.47 0.39 to 0.56 0.54 0.48 to 0.61 0.59 0.50 to 0.70
4th quartile 0.44 0.44 to 0.44 0.45 0.40 to 0.51 0.42 0.35 to 0.50 0.50 0.45 to 0.57 0.60 0.50 to 0.71
Respiratory system (ATC-R)
Education
Secondary 0.86 0.85 to 0.86 0.77 0.67 to 0.87 0.82 0.69 to 0.98 0.83 0.72 to 0.94 1.00 0.84 to 1.21
Tertiary 0.81 0.80 to 0.81 0.79 0.68 to 0.92 0.76 0.61 to 0.95 0.80 0.66 to 0.97 0.77 0.58 to 1.03
Income
2nd quartile 0.76 0.75 to 0.76 0.76 0.66 to 0.87 0.79 0.65 to 0.98 0.86 0.75 to 0.99 1.04 0.86 to 1.25
3rd quartile 0.68 0.68 to 0.69 0.74 0.64 to 0.86 0.69 0.57 to 0.85 0.85 0.73 to 0.98 1.02 0.84 to 1.24
4th quartile 0.63 0.63 to 0.63 0.69 0.59 to 0.81 0.64 0.52 to 0.79 0.83 0.71 to 0.96 1.25 1.04 to 1.51
Alimentary tract and metabolism (ATC-A)
Education
Secondary 0.84 0.84 to 0.84 0.85 0.77 to 0.94 0.81 0.71 to 0.93 0.84 0.75 to 0.94 0.98 0.85 to 1.14
Tertiary 0.68 0.67 to 0.68 0.72 0.62 to 0.83 0.64 0.53 to 0.77 0.81 0.68 to 0.96 0.94 0.76 to 1.17
Income
2nd quartile 0.74 0.74 to 0.75 0.73 0.65 to 0.81 0.83 0.72 to 0.96 0.85 0.76 to 0.96 0.88 0.77 to 1.01
3rd quartile 0.64 0.64 to 0.65 0.63 0.56 to 0.71 0.77 0.66 to 0.90 0.77 0.68 to 0.87 0.87 0.75 to 1.02
4th quartile 0.61 0.61 to 0.61 0.60 0.53 to 0.68 0.65 0.55 to 0.77 0.76 0.67 to 0.88 0.86 0.72 to 1.02
*Unpaired analysis treating twins as individuals while taking interdependence of observations within each individual and within twin pairs into
account. The interpretation of MR is the ratio of the mean number of prescriptions at a given time of, for example, an individual with a
secondary or tertiary education compared with a random individual with a primary education. MRs are adjusted for age and sex. Income and
education are mutually adjusted.
†Intrapair analysis of twins. The interpretation of MR is the ratio of the mean number of prescriptions at a given time of a twin with a
secondary or tertiary education compared with its co-twin with a primary education.
Italic typography indicates statistical significance at 5% level.
ATC, Anatomical Therapeutic Chemical classification system; DZSS, dizygotic same sex twins; MZ, monozygotic twins.
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the intrapair analysis.33 Generally, confounding from
unshared factors is thought to be more severe when con-
founders are less correlated than exposure.33 This may
or may not be true in our case, since we can only
hypothesise on the correlation of unmeasured confoun-
ders. Nevertheless, the correlation of education and
income (MZ=0.79, DZ=0.58 and MZ=0.49, DZ=0.33) are
more or less of the same magnitude as phenotypes like
cognitive ability35 and body mass index36 that have previ-
ously been investigated using similar designs. In any
case, as shown by Frisell et al35 in order for increased con-
founding to explain the attenuation of the association
observed in this study, the potential non-shared confoun-
ders would have to create a positive association between
education and prescription ﬁllings. In most cases,
however, we would expect a negative association,
although ﬁlling of prescription medicine is indeed a
complex health outcome and it is theoretically possible
for a confounder to have a dual effect on prescription
ﬁllings by (1) increasing the capability of getting the
relevant prescriptions, for example, due to more regular
heath checks or better understanding of symptoms (2)
at the same time reducing the need for prescription ﬁll-
ings due to better health status. Nevertheless, in a
Danish context health status does seem to be the main
determinant of prescription medicine10 37 38 and was
clearly associated with mortality in this data. Thus, in the
presence of non-shared confounding we would expect
the net effect of any confounding to produce a negative
association between education and prescription ﬁllings
resulting in a bias away from the null,33 and therefore it
could not explain the observed attenuation of effect in
the intrapair analyses observed in this study.
The ﬁnding of greatest attenuation in MZ twins is
compatible with the scenario of genetic confounding
described in the introduction. Since the genetic overlap
is greater in MZ twins than DZSS twins, one would
expect a larger attenuation in MZ twins, if genetic
factors gave rise to the confounding. However, a number
of other factors could produce a greater attenuation in
MZ twins: ﬁrst of all, the aforementioned measurement
error may be most pronounced in MZ twins, due to the
fact that increasing correlation in exposure will result in
a greater attenuation of intrapair parameter estimates.33
In addition, the comparison of strength of association
between MZ and DZ twins to indicate the source of
familial confounding relies on the equal environment
assumption: that is, MZ and DZ twins share their envir-
onment equally. However, this assumption may be chal-
lenged, and if it does not hold, that is, if MZ twins not
only share their genes but also their environment more
closely than DZ twins,39 shared environmental factors
could also produce a greater attenuation of effect in MZ
twins. However, the interplay between environment and
genes is complex, and it is conceivable that the environ-
ment to a certain extent is shaped in response to the
genetic dispositions of an individual. If, for instance, a
genetically determined similar appearance of MZ twins
also elicits a more similar treatment from their peers,
then these similar environmental stimuli can also be
ascribed to genetic factors.40
Thus, although several factors may contribute to the
observed attenuation of association between SEP and
ﬁlling of prescription drugs in the intrapair analyses and
to the differences in strength of association between MZ
and DZ twins, the ﬁndings suggest that a part of the
observed social inequality in prescription ﬁllings is
explained by either genetic or environmental factors
shared by twins.
The ﬁnding of a persistent association of particularly
income with ﬁllings of prescriptions for ATC-N drugs
clearly stood out from the general results. We therefore
carried out a post hoc subanalysis of speciﬁc categories
of ATC-N drugs to test whether it were certain types of
drugs driving the association. The analysis revealed that
it was mainly for analgesics and psycholeptics that the
Table 5 Results from a linear regression model showing number of daily defined doses (DDD) for all-purpose drugs
according to educational status and income in a population of Danish twins (n=24 370) stratified on zygosity
Unpaired analysis* Intrapair analysis†
Educational status DZSS n=15 788 MZ n=8582 DZSS MZ
Income DDD 95% CI DDD 95% CI DDD 95% CI DDD 95% CI
Secondary −287 −397 to −177 −289 −440 to −138 −245 −399 to −90 −143 −346 to 59
Tertiary −404 −531 to −277 −424 −606 to −243 −344 −557 to −131 −152 −440 to 136
2nd quartile −401 −541 to −260 −275 −463 to −88 −219 −383 to −54 18 −177 to 214
3rd quartile −541 −680 to −402 −451 −638 to −263 −367 −535 to −198 −83 −287 to 121
4th quartile −505 −648 to −363 −437 −630 to −243 −327 −512 to −142 16 −209 to 242
Results from unpaired and intrapair analyses are shown.
*Unpaired analysis treating twins as individuals while taking interdependence of observations within each individual and within twin pairs into
account. The interpretation of, for example, the education estimate is difference in the mean number of DDDs of an individual with a
secondary or tertiary education compared with a random individual with a primary education. The estimates are adjusted for age and sex.
Income and education are mutually adjusted.
†Intrapair analysis of twins. The interpretation of for example, the education estimate is the difference in the mean number of DDDs of a twin
with a secondary or tertiary education compared with its co-twin with a primary education.
Italic typography indicates statistical significance at 5% level.
DZSS, dizygotic same sex twins; MZ, monozygotic twins.
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association persisted, while the association was somewhat
attenuated for psychoanaleptics (primarily antidepres-
sants). This ﬁnding may support the notion of reverse
causation, that is, that health status inﬂuences SEP
rather than the other way around, since it is likely that
diagnoses such as chronic pain disorders, psychoses,
anxiety and bipolar disorders associated with these types
of drugs may affect the work ability and thus the income
of a person. Income is much more sensitive to reverse
causation than education, which is usually obtained
early in life and remains constant once it is obtained.
Existing literature
In this study we argue that ﬁllings of all-purpose and
system-speciﬁc drug prescriptions to some extent serve
as an indicator of general health status and of conditions
such as ischaemic heart disease, hypertension, COPD
and diabetes. The ﬁnding of weaker effects of SEP, when
underlying familial factors were taken into account,
accords with a large part of the life-course literature that
supports the importance of early life factors in the aeti-
ology of chronic disease in adulthood.41 42
In addition, a number of previous twin and sibling
studies have investigated the association between various
SEP indicators and health outcomes. While some studies
have shown strong or some evidence of a causal effect of
adult SEP43–47 other suggest no or little effect of SEP,
when familial factors have been adjusted for.22 48–51
Other studies show mixed results.21 23–25 47 52–54
However, the studies vary with respect to a number of
important parameters hampering overall comparisons.
Most importantly, investigated health outcomes differ
and may have different aetiologies and show different
social gradients and patterns of familial confounding,
but even for speciﬁc-health outcomes there is no clear
picture of evidence. For example, for mortality, two
sibling45 46 and two twin studies21 44 have investigated
the association with education. Although all studies
support some effect of education after controlling for
shared family factors, important differences exist: the
twin study by Madsen et al21 demonstrated an effect of
education within twins only in older cohorts of men, but
not in younger men and not in women. The inﬂuence
of shared family factors was thus suggested in the latter,
but not in the ﬁrst subgroup of this study. The two
sibling studies also suggested some effect of shared
family factors, while the twin study by Lundborg43 did
not support any such effect. For self-rated health, the
majority of the existing twin studies24 25 53 have shown
mixed results, although Osler et al47 and Lundborg43 did
ﬁnd a statistically signiﬁcant association between social
class respective education and self-rated health in the
intrapair analyses. One important reason for the incon-
sistencies may be that many studies have suffered from
power limitations in the intrapair analyses due to a small
number of events.21 23 25 47 53 This is not a concern in
this study, where almost all of the exposure discordant
twins contributed with information to the intrapair
analyses, thus providing some of the most powerful twin
results on social inequality in health to date.
Strengths and limitations
The twin approach is clearly a strength of this study,
since it makes it possible to adjust for unmeasured back-
ground factors shared by twins that may underlie the
association between SEP and health. Furthermore, the
large sample size and the long follow-up allow a great
number of events to be analysed. In addition, the use of
population-based registers has the advantage of relatively
little selection and measurement error in the study
population. Finally, this study not only focuses on pre-
scription medicine in general, but also on drugs target-
ing speciﬁc organ systems which may give us a better
idea of potential mechanisms.
Among study limitations is the fact that ﬁlling of pre-
scription medicine is not a perfect measure of health
status. We do, however, argue that the observed associ-
ation with mortality and the inverse relationship with
education and income likely reﬂect a greater need for
medicine among people of lower SEP. In case that access
to healthcare also plays a role, presumably favouring
people of high SEP, the social gradient in health status
in this study could be underestimated. Although data
did not contain information on over-the-counter medica-
tion, it only constitutes a minor part of the total drug
consumption in Denmark,7 and since we were interested
in drugs as an indicator of health status, it could be
argued that the most valid approach is to focus on drugs
that require a formal medical indication (ie,
prescription).
As models for counting processes only allow one event
at a time, the number of prescription ﬁllings was
deﬁned as the main outcome of interest. Therefore, it
was reassuring that the subanalysis on DDD led to
similar results.
Although the distribution of SEP indicators and pre-
scription ﬁllings were not entirely identical in twins and
the population-based sample, the associations between
SEP and prescription ﬁllings were indeed, which sup-
ports generalisability to the general population in line
with previous studies that show that health and mortality
in twins are similar to the background population.55 56
Furthermore, the fact that the analysis based only on dis-
cordant twin pairs show marginal results similar to those
based on the total twin sample was reassuring.
Conclusion and perspectives
In this study, based on a comprehensive twin cohort, we
observed a social inequality in ﬁllings of prescription
medicine, showing fewer prescription ﬁllings among
people with high SEP. This association attenuated within
twin pairs for most types of prescription ﬁllings, except
those targeting the nervous system. The attenuation was
most pronounced in MZ twins. Measurement error can
contribute to the observed attenuation of association,
but it is likely to account only for a minor fraction,
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considering the exposure and outcome measures in this
study. As for potential non-shared confounding we
would, if anything, expect it to bias the estimates away
from the null.
We therefore interpret the ﬁndings as an indication
that at least a part of the observed social inequality in
prescription ﬁllings is explained by shared familial
factors. The implications of these ﬁndings are by no
means a disqualiﬁcation of SEP as a determinant of
health, but rather an indication that family matters in
the production of social health inequalities; most likely
through early environment, and possibly also genetic
factors. Recognising biological components and early
life exposures as important explanatory factors may
improve our understanding of the multifaceted aetiology
of health inequalities over the life course and increase
the potential for effective and targeted interventions.
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